ASHLEY FOSTER: Open Payments
NPI 1265137723 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$298 in 15 payments from 5 companies in 2025. Trend: 2023 $351 · 2024 $452 · 2025 $298
Food & beverage: $298
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 10 | $178 |
| Pharming Healthcare, Inc. | 2 | $56 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: DUPIXENT, RUCONEST, KEYTRUDA, TEZSPIRE.
Industry payments across LA — which companies pay providers there.
